Presented by Austen BioInnovation Institute in Akron and sponsored by the Kauffman Foundation.

Join leading national experts and collaborate with your peers to explore how America can retain its lead in medical device development and innovation.


A two-day national conference focused on topics such as maximizing value for patient and healthcare systems, medical device complexity, regulatory innovation pathway, educating the next generation of value-driven engineers and real-world examples of Value-driven Engineering.  This is a unique opportunity to step to the front lines of medical innovation.

Why Value-driven Engineering?

Value-driven Engineering is a new paradigm to develop patient-centered innovative medical devices that seek to optimize clinical utility, reduce complexity for the end-user, and improve cost efficiency for the healthcare system.


April 22-24, 2012


The John S. Knight Center in Akron, Ohio


Leaders from the medical device industry, academia and the public and private sectors are encouraged to attend.  Confirmed speakers include:

  • Thomas Fogarty, MD, Founder, Fogarty Institute for Innovation
  • DeVon W. Griffin, PhD, Computational Simulations Project Manager, NASA Glenn Research Center
  • William J. Heetderks, PhD, MD, Director of Extramural Science Programs, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health
  • Mike Hess, Vice President of Corporate Technology and Innovation, Medtronic Inc.
  • Robert E. Litan, Vice President for Research and Policy, Ewing Marion Kauffman Foundation
  • Megan Moynahan, Associate Director of Technology and Innovation, Food and Drug Administration
  • Marc S. Penn, MD, PhD, FACC, Director, Research Cardiovascular Institute, Summa Health System
  • Luis M. Proenza, PhD, President, The University of Akron; Board of Directors, U.S. Council on Competititveness; Past Member, President’s Council of Advisors on Science and Technology

To see a full list of speakers, click here.